261 related articles for article (PubMed ID: 27637639)
1. Universal Bypass for Treatment of Symptomatic Moyamoya Disease or Moyamoya Syndrome. Analysis of a Personal Case Series on Behalf of the Italian Moyamoya Association.
Lanterna LA; Brembilla C; Gritti P; Bernucci C
Acta Neurochir Suppl; 2016; 123():129-32. PubMed ID: 27637639
[TBL] [Abstract][Full Text] [Related]
2. Surgical outcomes following encephaloduroarteriosynangiosis in North American adults with moyamoya.
Agarwalla PK; Stapleton CJ; Phillips MT; Walcott BP; Venteicher AS; Ogilvy CS
J Neurosurg; 2014 Dec; 121(6):1394-400. PubMed ID: 25280094
[TBL] [Abstract][Full Text] [Related]
3. Outcome of repeat revascularization surgery for moyamoya disease after an unsuccessful indirect revascularization. Clinical article.
Pandey P; Steinberg GK
J Neurosurg; 2011 Aug; 115(2):328-36. PubMed ID: 21529138
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China.
Liu XJ; Zhang D; Wang S; Zhao YL; Teo M; Wang R; Cao Y; Ye X; Kang S; Zhao JZ
J Neurosurg; 2015 Feb; 122(2):392-9. PubMed ID: 25423267
[TBL] [Abstract][Full Text] [Related]
5. Unstable moyamoya disease: clinical features and impact on perioperative ischemic complications.
Funaki T; Takahashi JC; Takagi Y; Kikuchi T; Yoshida K; Mitsuhara T; Kataoka H; Okada T; Fushimi Y; Miyamoto S
J Neurosurg; 2015 Feb; 122(2):400-7. PubMed ID: 25423271
[TBL] [Abstract][Full Text] [Related]
6. Effect of direct arterial bypass on the prevention of future stroke in patients with the hemorrhagic variety of moyamoya disease.
Kawaguchi S; Okuno S; Sakaki T
J Neurosurg; 2000 Sep; 93(3):397-401. PubMed ID: 10969936
[TBL] [Abstract][Full Text] [Related]
7. Moyamoya syndrome associated with neurofibromatosis Type 1: perioperative and long-term outcome after surgical revascularization.
Koss M; Scott RM; Irons MB; Smith ER; Ullrich NJ
J Neurosurg Pediatr; 2013 Apr; 11(4):417-25. PubMed ID: 23373626
[TBL] [Abstract][Full Text] [Related]
8. Down syndrome and moyamoya: clinical presentation and surgical management.
See AP; Ropper AE; Underberg DL; Robertson RL; Scott RM; Smith ER
J Neurosurg Pediatr; 2015 Jul; 16(1):58-63. PubMed ID: 25837890
[TBL] [Abstract][Full Text] [Related]
9. Radial Artery Grafts as Rescue Strategy for Patients with Moyamoya Disease for Whom Conventional Revascularization Failed.
Hori S; Acker G; Vajkoczy P
World Neurosurg; 2016 Jan; 85():77-84. PubMed ID: 26341437
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Moyamoya disease in the adult population with pial synangiosis.
Lin N; Aronson JP; Manjila S; Smith ER; Scott RM
J Neurosurg; 2014 Mar; 120(3):612-7. PubMed ID: 24405066
[TBL] [Abstract][Full Text] [Related]
11. Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome.
Smith ER; McClain CD; Heeney M; Scott RM
Neurosurg Focus; 2009 Apr; 26(4):E10. PubMed ID: 19335126
[TBL] [Abstract][Full Text] [Related]
12. Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease.
Fujimura M; Mugikura S; Kaneta T; Shimizu H; Tominaga T
Surg Neurol; 2009 Apr; 71(4):442-7. PubMed ID: 18514264
[TBL] [Abstract][Full Text] [Related]
13. Postoperative neurological deterioration in pediatric moyamoya disease: watershed shift and hyperperfusion.
Hayashi T; Shirane R; Fujimura M; Tominaga T
J Neurosurg Pediatr; 2010 Jul; 6(1):73-81. PubMed ID: 20593991
[TBL] [Abstract][Full Text] [Related]
14. Moyamoya syndrome associated with Down syndrome: outcome after surgical revascularization.
Jea A; Smith ER; Robertson R; Scott RM
Pediatrics; 2005 Nov; 116(5):e694-701. PubMed ID: 16263984
[TBL] [Abstract][Full Text] [Related]
15. Unilaterally symptomatic moyamoya disease in children: long-term follow-up of 20 patients.
Nagata S; Matsushima T; Morioka T; Matsukado K; Mihara F; Sasaki T; Fukui M
Neurosurgery; 2006 Oct; 59(4):830-6; discussion 836-7. PubMed ID: 17038947
[TBL] [Abstract][Full Text] [Related]
16. Stroke prevention by direct revascularization for patients with adult-onset moyamoya disease presenting with ischemia.
Kim T; Oh CW; Kwon OK; Hwang G; Kim JE; Kang HS; Cho WS; Bang JS
J Neurosurg; 2016 Jun; 124(6):1788-93. PubMed ID: 26636391
[TBL] [Abstract][Full Text] [Related]
17. Direct versus indirect bypass procedure for the treatment of ischemic moyamoya disease: results of an individualized selection strategy.
Nielsen TH; Abhinav K; Sussman ES; Han SS; Weng Y; Bell-Stephens T; ; Heit JJ; Steinberg GK
J Neurosurg; 2020 Jun; 134(5):1578-1589. PubMed ID: 32534489
[TBL] [Abstract][Full Text] [Related]
18. Direct versus indirect bypasses for adult ischemic-type moyamoya disease: a propensity score-matched analysis.
Deng X; Gao F; Zhang D; Zhang Y; Wang R; Wang S; Cao Y; Zhao Y; Pan Y; Liu X; Zhang Q; Zhao J
J Neurosurg; 2018 Jun; 128(6):1785-1791. PubMed ID: 28799875
[TBL] [Abstract][Full Text] [Related]
19. Moyamoya disease and Moyamoya syndrome: experience in Europe; choice of revascularisation procedures.
Khan N; Schuknecht B; Boltshauser E; Capone A; Buck A; Imhof HG; Yonekawa Y
Acta Neurochir (Wien); 2003 Dec; 145(12):1061-71; discussion 1071. PubMed ID: 14663563
[TBL] [Abstract][Full Text] [Related]
20. Clinical course, surgical management, and long-term outcome of moyamoya patients with rebleeding after an episode of intracerebral hemorrhage: An extensive follow-Up study.
Yoshida Y; Yoshimoto T; Shirane R; Sakurai Y
Stroke; 1999 Nov; 30(11):2272-6. PubMed ID: 10548656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
